These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16061546)

  • 21. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
    Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
    Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A frontal mucocele caused by an immune reconstitution inflammatory syndrome in a patient with HIV infection.
    Colebunders B; Claes G; Vlieghe E; Demeester R; Moerman F; Colebunders R
    Rhinology; 2008 Sep; 46(3):243-5. PubMed ID: 18853879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
    HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Coronary heart disease associated with the use of highly active antiretroviral therapy (HAART). A case report and review].
    Neumann T; Kondratieva J; Eggebrecht H; Wieneke H; Esser S; Bartel T; Erbel R
    Herz; 2005 Sep; 30(6):504-9. PubMed ID: 16170681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders.
    Mijch A; Burgess P; Judd F; Grech P; Komiti A; Hoy J; Lloyd JH; Gibbie T; Street A
    HIV Med; 2006 May; 7(4):205-12. PubMed ID: 16630032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
    Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
    HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection.
    Loke WC; Spittle MF; Mitchell S; Kulasegaram R
    Int J STD AIDS; 2006 Aug; 17(8):565-6. PubMed ID: 16925908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients.
    Palacios R; Santos J; García A; Castells E; González M; Ruiz J; Márquez M
    HIV Med; 2006 Jan; 7(1):10-5. PubMed ID: 16313287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women.
    Grosch-Woerner I; Puch K; Maier RF; Niehues T; Notheis G; Patel D; Casteleyn S; Feiterna-Sperling C; Groeger S; Zaknun D;
    HIV Med; 2008 Jan; 9(1):6-13. PubMed ID: 18199167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hospitalizations of pregnant HIV-infected women in the United States in the era of highly active antiretroviral therapy (HAART).
    Bansil P; Jamieson DJ; Posner SF; Kourtis AP
    J Womens Health (Larchmt); 2007 Mar; 16(2):159-62. PubMed ID: 17388731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly active antiretroviral therapy access and neurological complications of human immunodeficiency virus infection: impact versus resources in Brazil.
    Silva MT; Araújo A
    J Neurovirol; 2005; 11 Suppl 3():11-5. PubMed ID: 16540448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral vasculitis after initiation antiretroviral therapy.
    van der Ven AJ; van Oostenbrugge RJ; Kubat B; Tervaert JW
    AIDS; 2002 Nov; 16(17):2362-4. PubMed ID: 12441820
    [No Abstract]   [Full Text] [Related]  

  • 33. Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India.
    Saghayam S; Kumarasamy N; Cecelia AJ; Solomon S; Mayer K; Wanke C
    Clin Infect Dis; 2007 Jan; 44(2):295-300. PubMed ID: 17173234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leprosy occurring as immune reconstitution syndrome.
    Deps PD; Lockwood DN
    Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):966-8. PubMed ID: 18639911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cutaneous drug reactions in HIV-infected patients in the HAART era].
    Blanes M; Belinchón I; Portilla J
    Actas Dermosifiliogr; 2009 May; 100(4):253-65. PubMed ID: 19463228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Two patients with isolated vasculitis of the central nervous system].
    van der Ven AJ; van Oostenbrugge RJ; Tervaert JW
    Ned Tijdschr Geneeskd; 2002 Jul; 146(27):1300-1; author reply 1301. PubMed ID: 12138680
    [No Abstract]   [Full Text] [Related]  

  • 37. Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy.
    Solmone M; Girardi E; Lalle E; Abbate I; D'Arminio Monforte A; Cozzi-Lepri A; Alessandrini A; Piscopo R; Ebo F; Cosco L; Antonucci G; Ippolito G; Capobianchi MR; ;
    Antivir Ther; 2006; 11(1):87-94. PubMed ID: 16518964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and prevalence of the metabolic syndrome in a cohort of naive HIV-infected patients: prospective analysis at 48 weeks of highly active antiretroviral therapy.
    Palacios R; Santos J; González M; Ruiz J; Márquez M
    Int J STD AIDS; 2007 Mar; 18(3):184-7. PubMed ID: 17362552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapy.
    Ostrowski SR; Katzenstein TL; Pedersen M; Høyer-Hansen G; Gerstoft J; Pedersen BK; Ullum H
    Scand J Immunol; 2006 Jun; 63(6):478-86. PubMed ID: 16764702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sexual dysfunction in the highly active antiretroviral therapy era.
    Collazos J
    AIDS Rev; 2007; 9(4):237-45. PubMed ID: 18219367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.